LIGAND PHARMACEUTICALS INC Insider Trading for August 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for August 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Sell | S | 258.25 | 3,500 | 903,875 | 85,419 | 88.9 K to 85.4 K (-3.94 %) |
| Aug 29 2018 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Option Exercise | M | 85.79 | 11,540 | 990,017 | 6,924 | |
| Aug 29 2018 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Sell | S | 256.69 | 18,357 | 4,712,060 | 6,742 | 25.1 K to 6.7 K (-73.14 %) |
| Aug 29 2018 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Buy | M | 85.79 | 11,540 | 990,017 | 25,099 | 13.6 K to 25.1 K (+85.11 %) |
| Aug 29 2018 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Option Exercise | M | 85.79 | 11,540 | 990,017 | 6,924 | |
| Aug 29 2018 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Sell | S | 256.69 | 18,357 | 4,712,060 | 6,742 | 25.1 K to 6.7 K (-73.14 %) |
| Aug 29 2018 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Buy | M | 85.79 | 11,540 | 990,017 | 25,099 | 13.6 K to 25.1 K (+85.11 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 241.81 | 26,862 | 6,495,559 | 51,392 | 78.3 K to 51.4 K (-34.33 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 245.00 | 1,080 | 264,600 | 78,254 | 79.3 K to 78.3 K (-1.36 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 239.50 | 3,167 | 758,497 | 45,056 | 48.2 K to 45.1 K (-6.57 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 239.93 | 5,833 | 1,399,505 | 48,223 | 54.1 K to 48.2 K (-10.79 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Option Exercise | M | 14.47 | 12,993 | 188,009 | 159,000 | |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Option Exercise | M | 14.47 | 3,007 | 43,511 | 171,993 | |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Sell | S | 243.00 | 12,993 | 3,157,299 | 88,919 | 101.9 K to 88.9 K (-12.75 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Buy | M | 14.47 | 12,993 | 188,009 | 101,912 | 88.9 K to 101.9 K (+14.61 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Sell | S | 241.33 | 21,507 | 5,190,261 | 88,919 | 110.4 K to 88.9 K (-19.48 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Buy | M | 14.47 | 3,007 | 43,511 | 110,426 | 107.4 K to 110.4 K (+2.80 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | M | 32.30 | 7,335 | 236,921 | 0 | |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | M | 12.53 | 7,335 | 91,908 | 0 | |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | M | 10.12 | 7,335 | 74,230 | 0 | |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | M | 9.60 | 5,000 | 48,000 | 0 | |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Sell | S | 240.05 | 42,287 | 10,150,808 | 24,524 | 66.8 K to 24.5 K (-63.29 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | M | 32.30 | 7,335 | 236,921 | 66,811 | 59.5 K to 66.8 K (+12.33 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | M | 12.53 | 7,335 | 91,908 | 59,476 | 52.1 K to 59.5 K (+14.07 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | M | 10.12 | 7,335 | 74,230 | 52,141 | 44.8 K to 52.1 K (+16.37 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | M | 9.60 | 5,000 | 48,000 | 44,806 | 39.8 K to 44.8 K (+12.56 %) |
| Aug 07 2018 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Payment of Exercise | F | 226.74 | 836 | 189,555 | 13,559 | 14.4 K to 13.6 K (-5.81 %) |